25 research outputs found

    Towards a cancer mission in Horizon Europe: recommendations.

    Get PDF
    A comprehensive translational cancer research approach focused on personalized and precision medicine, and covering the entire cancer research-care-prevention continuum has the potential to achieve in 2030 a 10-year cancer-specific survival for 75% of patients diagnosed in European Union (EU) member states with a well-developed healthcare system. Concerted actions across this continuum that spans from basic and preclinical research through clinical and prevention research to outcomes research, along with the establishment of interconnected high-quality infrastructures for translational research, clinical and prevention trials and outcomes research, will ensure that science-driven and social innovations benefit patients and individuals at risk across the EU. European infrastructures involving comprehensive cancer centres (CCCs) and CCC-like entities will provide researchers with access to the required critical mass of patients, biological materials and technological resources and can bridge research with healthcare systems. Here, we prioritize research areas to ensure a balanced research portfolio and provide recommendations for achieving key targets. Meeting these targets will require harmonization of EU and national priorities and policies, improved research coordination at the national, regional and EU level and increasingly efficient and flexible funding mechanisms. Long-term support by the EU and commitment of Member States to specialized schemes are also needed for the establishment and sustainability of trans-border infrastructures and networks. In addition to effectively engaging policymakers, all relevant stakeholders within the entire continuum should consensually inform policy through evidence-based advice

    Magnetosheath Turbulence

    No full text
    International audienc

    Towards marketing biomethane in France—French consumers’ perception of biomethane

    No full text
    Abstract Background French energy policy calls for ambitious growth in the biogas sector, with the quantity of biomethane fed into the public grid targeted at 8 TWh per year by 2023. Although today biomethane in France serves predominantly as vehicle fuel, the domestic heating market, with its high share of gas heating, should see biogas growth in the future, provided consumer demand can develop and suppliers can emerge savvy enough to respond to that demand. Methods Towards this end, we conducted qualitative interviews with some mixed-methods elements with French consumers in the South of France to explore their knowledge of and attitudes towards biogas as well as their preferences for specific product features of biomethane-based gas products. Results We found that today’s consumers have little knowledge of biogas production and feel uncertain and doubtful about products. They can name reasons, both environmental and financial, for and against biogas. They favor biomethane products from agricultural residues and biodegradable household waste, rejecting energy crops. In principle, they value local production by small suppliers, find ecolabels helpful, and look favorably upon extra environmental benefits accruing from the sale of biogas. However, consumers labor under misconceptions regarding the costs of biomethane production. Conclusion Crafting communication strategies that address widespread consumer doubt and consumer perceived risk is the challenge suppliers face in order to allow consumers to make a well-based decision

    Magnetosheath Turbulence

    No full text
    International audienc

    Magnetosheath Turbulence

    No full text
    International audienc
    corecore